Bluejay Diagnostics, Inc. (BJDX) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$6.95M | +3.0% |
| 2024 | -$7.17M | +30.5% |
| 2023 | -$10.31M | -10.7% |
| 2022 | -$9.32M | -188.5% |
| 2021 | -$3.23M | -170.0% |
| 2020 | -$1.20M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$6.95M | +3.0% |
| 2024 | -$7.17M | +30.5% |
| 2023 | -$10.31M | -10.7% |
| 2022 | -$9.32M | -188.5% |
| 2021 | -$3.23M | -170.0% |
| 2020 | -$1.20M | — |